Clinical utility of circulating tumor DNA sequencing with a large panel in patients with advanced soft-tissue sarcomas

Cancer Commun (Lond). 2023 Sep;43(9):1051-1054. doi: 10.1002/cac2.12461. Epub 2023 Jul 5.

Authors

Julie Blanchi^#^{1

2}, Sofiane Taleb^#³, Arnaud Bayle³, Benjamin Verret⁴, Maud Toulmonde⁵, Mariella Spalato-Ceruso^{1

5}, Paul Dubos⁵, Yech'an Laizet⁵, Melissa Alame², Emmanuel Khalifa², Antoine Italiano^{1

3

5

6}

Affiliations

¹ INSERM, Unité 1312, SARCOTARGET team, Bordeaux, France.
² Department of BioPathology, Institut Bergonié, Bordeaux, France.
³ Drug Developpement Department, Gustave Roussy, Villejuif, France.
⁴ Department of Medicine, Gustave Roussy, Villejuif, France.
⁵ Sarcoma Unit, Institut Bergonié, Bordeaux, France.
⁶ Faculty of Medicine, University of Bordeaux, Bordeaux, France.

^# Contributed equally.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Circulating Tumor DNA* / genetics
Humans
Sarcoma* / genetics
Soft Tissue Neoplasms* / genetics

Substances

Circulating Tumor DNA